131 related articles for article (PubMed ID: 28539564)
1. Improvement of Local Cell Delivery Using Helix Transendocardial Delivery Catheter in a Porcine Heart.
Mitsutake Y; Pyun WB; Rouy D; Foo CWP; Stertzer SH; Altman P; Ikeno F
Int Heart J; 2017 May; 58(3):435-440. PubMed ID: 28539564
[TBL] [Abstract][Full Text] [Related]
2. Comparison of transendocardial and intracoronary CD34+ cell transplantation in patients with nonischemic dilated cardiomyopathy.
Vrtovec B; Poglajen G; Lezaic L; Sever M; Socan A; Domanovic D; Cernelc P; Torre-Amione G; Haddad F; Wu JC
Circulation; 2013 Sep; 128(11 Suppl 1):S42-9. PubMed ID: 24030420
[TBL] [Abstract][Full Text] [Related]
3. Transendocardial and transepicardial intramyocardial fibroblast growth factor-2 administration: myocardial and tissue distribution.
Laham RJ; Post M; Rezaee M; Donnell-Fink L; Wykrzykowska JJ; Lee SU; Baim DS; Sellke FW
Drug Metab Dispos; 2005 Aug; 33(8):1101-7. PubMed ID: 15879496
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive in vivo imaging of cardiac stem/progenitor cell biodistribution and retention after intracoronary and intramyocardial delivery in a swine model of chronic ischemia reperfusion injury.
Collantes M; Pelacho B; García-Velloso MJ; Gavira JJ; Abizanda G; Palacios I; Rodriguez-Borlado L; Álvarez V; Prieto E; Ecay M; Larequi E; Peñuelas I; Prósper F
J Transl Med; 2017 Mar; 15(1):56. PubMed ID: 28288654
[TBL] [Abstract][Full Text] [Related]
5. Transendocardial cell injection is not superior to intracoronary infusion in a porcine model of ischaemic cardiomyopathy: a study on delivery efficiency.
van der Spoel TI; Vrijsen KR; Koudstaal S; Sluijter JP; Nijsen JF; de Jong HW; Hoefer IE; Cramer MJ; Doevendans PA; van Belle E; Chamuleau SA
J Cell Mol Med; 2012 Nov; 16(11):2768-76. PubMed ID: 22697212
[TBL] [Abstract][Full Text] [Related]
6. Electromagnetic guidance for catheter-based transendocardial injection: a platform for intramyocardial angiogenesis therapy. Results in normal and ischemic porcine models.
Kornowski R; Leon MB; Fuchs S; Vodovotz Y; Flynn MA; Gordon DA; Pierre A; Kovesdi I; Keiser JA; Epstein SE
J Am Coll Cardiol; 2000 Mar; 35(4):1031-9. PubMed ID: 10732905
[TBL] [Abstract][Full Text] [Related]
7. Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction.
Perin EC; Silva GV; Assad JA; Vela D; Buja LM; Sousa AL; Litovsky S; Lin J; Vaughn WK; Coulter S; Fernandes MR; Willerson JT
J Mol Cell Cardiol; 2008 Mar; 44(3):486-95. PubMed ID: 18061611
[TBL] [Abstract][Full Text] [Related]
8. Optimized delivery system achieves enhanced endomyocardial stem cell retention.
Behfar A; Latere JP; Bartunek J; Homsy C; Daro D; Crespo-Diaz RJ; Stalboerger PG; Steenwinckel V; Seron A; Redfield MM; Terzic A
Circ Cardiovasc Interv; 2013 Dec; 6(6):710-8. PubMed ID: 24326777
[TBL] [Abstract][Full Text] [Related]
9. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure.
Perin EC; Dohmann HF; Borojevic R; Silva SA; Sousa AL; Mesquita CT; Rossi MI; Carvalho AC; Dutra HS; Dohmann HJ; Silva GV; Belém L; Vivacqua R; Rangel FO; Esporcatte R; Geng YJ; Vaughn WK; Assad JA; Mesquita ET; Willerson JT
Circulation; 2003 May; 107(18):2294-302. PubMed ID: 12707230
[TBL] [Abstract][Full Text] [Related]
10. Dynamic tracking during intracoronary injection of 18F-FDG-labeled progenitor cell therapy for acute myocardial infarction.
Doyle B; Kemp BJ; Chareonthaitawee P; Reed C; Schmeckpeper J; Sorajja P; Russell S; Araoz P; Riederer SJ; Caplice NM
J Nucl Med; 2007 Oct; 48(10):1708-14. PubMed ID: 17909258
[TBL] [Abstract][Full Text] [Related]
11. Assessment of safety, accuracy, and human CD34+ cell retention after intramyocardial injections with a helical needle catheter in a porcine model.
Kumar A; Haralampus CA; Hughes M; Rouy D; Cresswell N; Braun R; Turner D; Amrani D; Motlagh D; Schaer GL
Catheter Cardiovasc Interv; 2013 May; 81(6):970-7. PubMed ID: 22581763
[TBL] [Abstract][Full Text] [Related]
12. Effects of adipose tissue-derived stem cell therapy after myocardial infarction: impact of the route of administration.
Rigol M; Solanes N; Farré J; Roura S; Roqué M; Berruezo A; Bellera N; Novensà L; Tamborero D; Prat-Vidal C; Huzman MA; Batlle M; Hoefsloot M; Sitges M; Ramírez J; Dantas AP; Merino A; Sanz G; Brugada J; Bayés-Genís A; Heras M
J Card Fail; 2010 Apr; 16(4):357-66. PubMed ID: 20350704
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic cardiospheres delivered via percutaneous transendocardial injection increase viable myocardium, decrease scar size, and attenuate cardiac dilatation in porcine ischemic cardiomyopathy.
Yee K; Malliaras K; Kanazawa H; Tseliou E; Cheng K; Luthringer DJ; Ho CS; Takayama K; Minamino N; Dawkins JF; Chowdhury S; Duong DT; Seinfeld J; Middleton RC; Dharmakumar R; Li D; Marbán L; Makkar RR; Marbán E
PLoS One; 2014; 9(12):e113805. PubMed ID: 25460005
[TBL] [Abstract][Full Text] [Related]
14. Comparison of transendocardial and retrograde coronary venous intramyocardial catheter delivery systems in healthy and infarcted pigs.
Baklanov DV; Moodie KM; McCarthy FE; Mandrusov E; Chiu J; Aswonge G; Cheng J; Chow M; Simons M; de Muinck ED
Catheter Cardiovasc Interv; 2006 Sep; 68(3):416-23. PubMed ID: 16892441
[TBL] [Abstract][Full Text] [Related]
15. Widespread Myocardial Delivery of Heart-Derived Stem Cells by Nonocclusive Triple-Vessel Intracoronary Infusion in Porcine Ischemic Cardiomyopathy: Superior Attenuation of Adverse Remodeling Documented by Magnetic Resonance Imaging and Histology.
Tseliou E; Kanazawa H; Dawkins J; Gallet R; Kreke M; Smith R; Middleton R; Valle J; Marbán L; Kar S; Makkar R; Marbán E
PLoS One; 2016; 11(1):e0144523. PubMed ID: 26784932
[TBL] [Abstract][Full Text] [Related]
16. Tissue distribution of 18F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction.
Kang WJ; Kang HJ; Kim HS; Chung JK; Lee MC; Lee DS
J Nucl Med; 2006 Aug; 47(8):1295-301. PubMed ID: 16883008
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery.
Terrovitis J; Lautamäki R; Bonios M; Fox J; Engles JM; Yu J; Leppo MK; Pomper MG; Wahl RL; Seidel J; Tsui BM; Bengel FM; Abraham MR; Marbán E
J Am Coll Cardiol; 2009 Oct; 54(17):1619-26. PubMed ID: 19833262
[TBL] [Abstract][Full Text] [Related]
18. Targeted transendocardial therapeutic delivery guided by MRI-x-ray image fusion.
Tomkowiak MT; Klein AJ; Vigen KK; Hacker TA; Speidel MA; VanLysel MS; Raval AN
Catheter Cardiovasc Interv; 2011 Sep; 78(3):468-78. PubMed ID: 21413125
[TBL] [Abstract][Full Text] [Related]
19. The safety of autologous intracoronary stem cell injections in a porcine model of chronic myocardial ischemia.
Bhakta S; Greco NJ; Finney MR; Scheid PE; Hoffman RD; Joseph ME; Banks JJ; Laughlin MJ; Pompili VJ
J Invasive Cardiol; 2006 May; 18(5):212-8. PubMed ID: 16670448
[TBL] [Abstract][Full Text] [Related]
20. Clinical Safety Profile of Transendocardial Catheter Injection Systems: A Plea for Uniform Reporting.
Raval AN; Pepine CJ
Cardiovasc Revasc Med; 2021 Jan; 22():100-108. PubMed ID: 32651159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
